Sign in
4

Changes in Ownership

Stoke Therapeutics, Inc. Filed Acc 0001415889-25-022226

GENERAL COUNSEL & CORP SEC acquired 6,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Allan Jonathan GENERAL COUNSEL & CORP SEC 2025-08-14 Option exercise +6,000 25,631 D
Derivatives
Allan Jonathan GENERAL COUNSEL & CORP SEC 2025-08-14 Grant or award · Performance Stock Units +12,000 12,000 D
Allan Jonathan GENERAL COUNSEL & CORP SEC 2025-08-14 Option exercise · Performance Stock Units −6,000 6,000 D
Loading xslF345X05/form4-08192025_120830.xml…